RICCIUTI, BIAGIO

RICCIUTI, BIAGIO  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)  

Dottorandi  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.032 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable Cortellini A.; Bersanelli M.; Buti S.; Cannita K.; Santini D.; Perrone F.; Giusti R.; Tiseo M.; M...ichiara M.; Di Marino P.; Tinari N.; De Tursi M.; Zoratto F.; Veltri E.; Marconcini R.; Malorgio F.; Russano M.; Anesi C.; Zeppola T.; Filetti M.; Marchetti P.; Botticelli A.; Antonini Cappellini G.C.; De Galitiis F.; Vitale M.G.; Rastelli F.; Pergolesi F.; Berardi R.; Rinaldi S.; Tudini M.; Silva R.R.; Pireddu A.; Atzori F.; Chiari R.; Ricciuti B.; De Giglio A.; Iacono D.; Gelibter A.; Occhipinti M.A.; Parisi A.; Porzio G.; Fargnoli M.C.; Ascierto P.A.; Ficorella C.; Natoli C. 2019-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista s40425-019-0527-y.pdf7782371.zip
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions Cortellini A.; Barrichello A.P.C.; Alessi J.V.; Ricciuti B.; Vaz V.R.; Newsom-Davis T.; Evans J.S....; Lamberti G.; Pecci F.; Viola P.; D'Alessio A.; Fulgenzi C.A.M.; Awad M.M.; Pinato D.J. 2022-01-01 ANNALS OF ONCOLOGY - 1.04 Replica / breve intervento (e simili) -
Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience Ricciuti B.; Baglivo S.; De Giglio A.; Chiari R. 2018-01-01 THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE - 1.01 Articolo in rivista ricciuti-et-al-2018-afatinib-in-the-first-line-treatment-of-patients-with-non-small-cell-lung-cancer-clinical-evidence.pdf
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events Cortellini A.; Bersanelli M.; Santini D.; Buti S.; Tiseo M.; Cannita K.; Perrone F.; Giusti R.; D...e Tursi M.; Zoratto F.; Marconcini R.; Russano M.; Zeppola T.; Anesi C.; Filetti M.; Marchetti P.; Botticelli A.; Gelibter A.; De Galitiis F.; Vitale M.G.; Rastelli F.; Tudini M.; Silva R.R.; Atzori F.; Chiari R.; Ricciuti B.; De Giglio A.; Migliorino M.R.; Mallardo D.; Vanella V.; Mosillo C.; Bracarda S.; Rinaldi S.; Berardi R.; Natoli C.; Ficorella C.; Porzio G.; Ascierto P.A. 2020-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy Cortellini A.; Ricciuti B.; Facchinetti F.; Alessi J.V.M.; Venkatraman D.; Dall'Olio F.G.; Craver...o P.; Vaz V.R.; Ottaviani D.; Majem M.; Piedra A.; Sullivan I.; Lee K.A.; Lamberti G.; Hussain N.; Clark J.; Bolina A.; Barba A.; Benitez J.C.; Gorria T.; Mezquita L.; Hoton D.; Aboubakar Nana F.; Besse B.; Awad M.M.; Pinato D.J. 2021-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Antibody–drug conjugates for lung cancer in the era of personalized oncology Ricciuti B.; Lamberti G.; Andrini E.; Genova C.; De Giglio A.; Bianconi V.; Sahebkar A.; Chiari R....; Pirro M. 2021-01-01 SEMINARS IN CANCER BIOLOGY - 1.01 Articolo in rivista -
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC Ricciuti B.; Naqash A.R.; Naidoo J.; Sehgal K.; Miller A.; Kehl K.; Venkatraman D.; Sands J.; Lam...berti G.; Recondo G.; Zhang J.; Macherla S.; Baig S.; Walker P.; Rangachari D.; Gainor J.F.; Costa D.B.; Rizvi N.; Sholl L.M.; Nishino M.; Henick B.; Farago A.F.; Awad M.M. 2020-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista 1-s2.0-S2666364320300977-main.pdfScienceDirect_files_21Apr2023_09-58-05.374.zip
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers with Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels Ricciuti B.; Wang X.; Alessi J.V.; Rizvi H.; Mahadevan N.R.; Li Y.Y.; Polio A.; Lindsay J.; Umeto...n R.; Sinha R.; Vokes N.I.; Recondo G.; Lamberti G.; Lawrence M.; Vaz V.R.; Leonardi G.C.; Plodkowski A.J.; Gupta H.; Cherniack A.D.; Tolstorukov M.Y.; Sharma B.; Felt K.D.; Gainor J.F.; Ravi A.; Getz G.; Schalper K.A.; Henick B.; Forde P.; Anagnostou V.; Janne P.A.; Van Allen E.M.; Nishino M.; Sholl L.M.; Christiani D.C.; Lin X.; Rodig S.J.; Hellmann M.D.; Awad M.M. 2022-01-01 JAMA ONCOLOGY - 1.01 Articolo in rivista jamaoncology_ricciuti_2022_oi_220022_1671559773.22536(1).pdfjamaoncol-e221981-s001.pdf
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer Ricciuti B.; Brambilla M.; Cortellini A.; De Giglio A.; Ficorella C.; Sidoni A.; Bellezza G.; Cri...no L.; Ludovini V.; Baglivo S.; Metro G.; Chiari R. 2020-01-01 CLINICAL & TRANSLATIONAL ONCOLOGY - 1.01 Articolo in rivista -
Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer Lamberti G.; Spurr L.F.; Li Y.; Ricciuti B.; Recondo G.; Umeton R.; Nishino M.; Sholl L.M.; Meyer...son M.L.; Cherniack A.D.; Awad M.M. 2020-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort (Cancer Immunology, Immunotherapy, (2020), 69, 7, (1177-1187), 10.1007/s00262-020-02536-5) Naqash A.R.; Ricciuti B.; Owen D.H.; Florou V.; Toi Y.; Cherry C.; Hafiz M.; De Giglio A.; Muzaff...ar M.; Patel S.H.; Sugawara S.; Burkart J.; Park W.; Chiari R.; Sugisaka J.; Otterson G.A.; de Lima Lopes G.; Walker P.R. 2020-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status Ricciuti B.; Arbour K.C.; Lin J.J.; Vajdi A.; Vokes N.; Hong L.; Zhang J.; Tolstorukov M.Y.; Li Y....Y.; Spurr L.F.; Cherniack A.D.; Recondo G.; Lamberti G.; Wang X.; Venkatraman D.; Alessi J.V.; Vaz V.R.; Rizvi H.; Egger J.; Plodkowski A.J.; Khosrowjerdi S.; Digumarthy S.; Park H.; Vaz N.; Nishino M.; Sholl L.M.; Barbie D.; Altan M.; Heymach J.V.; Skoulidis F.; Gainor J.F.; Hellmann M.D.; Awad M.M. 2022-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer Ricciuti B.; Alessi J.V.; Elkrief A.; Wang X.; Cortellini A.; Li Y.Y.; Vaz V.R.; Gupta H.; Pecci ...F.; Barrichello A.; Lamberti G.; Nguyen T.; Lindsay J.; Sharma B.; Felt K.; Rodig S.J.; Nishino M.; Sholl L.M.; Barbie D.A.; Negrao M.V.; Zhang J.; Cherniack A.D.; Heymach J.V.; Meyerson M.; Ambrogio C.; Janne P.A.; Arbour K.C.; Pinato D.J.; Skoulidis F.; Schoenfeld A.J.; Awad M.M.; Luo J. 2022-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation Baglivo S.; Ricciuti B.; Ludovini V.; Metro G.; Siggillino A.; De Giglio A.; Chiari R. 2018-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Ductal breast carcinoma metastatic to the stomach resembling primary linitis plastica in a male patient Ricciuti B.; Leonardi G.C.; Ravaioli N.; De Giglio A.; Brambilla M.; Prosperi E.; Ribacchi F.; Me...acci M.; Crino L.; Maiettini D.; Chiari R.; Metro G. 2016-01-01 JOURNAL OF BREAST CANCER - 1.01 Articolo in rivista -
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? De Giglio A.; Porreca R.; Brambilla M.; Metro G.; Prosperi E.; Bellezza G.; Pirro M.; Chiari R.; ...Ricciuti B. 2018-01-01 THROMBOSIS RESEARCH - 1.01 Articolo in rivista -
Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease Abu-Sbeih H.; Faleck D.M.; Ricciuti B.; Mendelsohn R.B.; Naqash A.R.; Cohen J.V.; Sellers M.C.; B...alaji A.; Ben-Betzalel G.; Hajir I.; Zhang J.; Awad M.M.; Leonardi G.C.; Johnson D.B.; Pinato D.J.; Owen D.H.; Weiss S.A.; Lamberti G.; Lythgoe M.P.; Manuzzi L.; Arnold C.; Qiao W.; Naidoo J.; Markel G.; Powell N.; Yeung S.-C.J.; Sharon E.; Dougan M.; Wang Y. 2020-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista JCO.19.01674.pdf
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer Ricciuti B.; Recondo G.; Spurr L.F.; Li Y.Y.; Lamberti G.; Venkatraman D.; Umeton R.; Cherniack A....D.; Nishino M.; Sholl L.M.; Shapiro G.I.; Awad M.M.; Cheng M.L. 2020-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis Ricciuti B.; Genova C.; De Giglio A.; Bassanelli M.; Dal Bello M.G.; Metro G.; Brambilla M.; Bagl...ivo S.; Grossi F.; Chiari R. 2019-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista -